Neuroleptic Malignant Syndrome.
Wijdicks EFM, Ropper AH.
N Engl J Med. 2024 Sep 26;391(12):1130-1138. doi: 10.1056/NEJMra2404606.
[Haloperidol poisoning in pediatric patients].
López-Valdés JC.
Gac Med Mex. 2017 Jan-Feb;153(1):125-128.
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia.
Tardy M, Huhn M, Kissling W, Engel RR, Leucht S.
Cochrane Database Syst Rev. 2014 Jul 9;2014(7):CD009268. doi: 10.1002/14651858.CD009268.pub2.
Haloperidol-induced liver disease.
Fuller CM, Yassinger S, Donlon P, Imperato TJ, Ruebner B.
West J Med. 1977 Dec;127(6):515-8.
[Haloperidol poisoning].
Filippa R, Toso A, Cordero J, Olivos Y.
Rev Chil Pediatr. 1976 Sep-Dec;47(5-6):369-71.
Haloperidol versus placebo for schizophrenia.
Adams CE, Bergman H, Irving CB, Lawrie S.
Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD003082. doi: 10.1002/14651858.CD003082.pub3.
Neuroleptic dysphoria.
Emerich DF, Sanberg PR.
Biol Psychiatry. 1991 Feb 1;29(3):201-3. doi: 10.1016/0006-3223(91)91281-u.
[The neurotoxicity of pyridinium metabolites of haloperidol].
Górska A, Marszałł M, Sloderbach A.
Postepy Hig Med Dosw (Online). 2015 Oct 19;69:1169-75. doi: 10.5604/17322693.1175009.
Haloperidol update: 1975.
Ayd FJ Jr.
Proc R Soc Med. 1976;69 suppl 1(Suppl 1):14-22. doi: 10.1177/00359157760690S104.
Propranolol-induced psychosis.
McGahan DJ, Wojslaw A, Prasad V, Blankenship S.
Drug Intell Clin Pharm. 1984 Jul-Aug;18(7-8):601-3. doi: 10.1177/106002808401800709.
